Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota

1. 32.
   Corrected

   Exploring Microbial Diversity and Taxonomy Using SSU rRNA Hypervariable Tag Sequencing · 2008

2. 47.

   Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma · 2013

3. 69.

   Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer · 2012

4. 88.

   Cancer classification using the Immunoscore: a worldwide task force · 2012

5. 95.

   Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome · 2010

6. 110.

   Towards the Human Colorectal Cancer Microbiome · 2011

7. 140.

   Gut mucosal microbiome across stages of colorectal carcinogenesis · 2015

8. 167.

   Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans · 2017

9. 187.

   Microbial Ecology along the Gastrointestinal Tract · 2017

10. 209.

    Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut · 2018

11. 210.

    Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study · 2019

12. 232.

    The B-Side of Cancer Immunity: The Underrated Tune · 2019

13. 235.

    Revised Estimates for the Number of Human and Bacteria Cells in the Body · 2016

14. 242.

    B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma · 2019

15. 252.

    Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients · 2019

16. 254.

    The Prognostic Importance of CD20+ B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets · 2019

17. 264.

    Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices · 2020

18. 269.
    Corrected

    TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer · 2020

19. 278.

    A decade of immune-checkpoint inhibitors in cancer therapy · 2020

268 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.